Abstract Clinical trials of typhoid conjugate vaccine (TCV) are ongoing in 4 countries. Early data confirm safety, tolerability, and immunogenicity of typhoid conjugate vaccine, and early efficacy results are promising. These data support World Health Organization recommendations and planned country introductions. Forthcoming trial data will continue to inform programmatic use of typhoid conjugate vaccine.
All Keywords
【저자키워드】 clinical trials, Conjugate vaccine, typhoid, TyVAC,
【저자키워드】 clinical trials, Conjugate vaccine, typhoid, TyVAC,